Innovation in Obesity Pathways - Market Engagement Opportunity

Description

NHS Surrey Heartlands and NHS Sussex ICBs are preparing to bid for grant funding under the Obesity Pathway Innovation Programme (OPIP): Strand 3-Combined Access and Management for Healthy Ageing and Tackling Obesity, a national innovation competition jointly funded by the Department for Science, Innovation and Technology (DSIT) and Eli Lilly and Company Limited, with up to £85 million available across the UK. To inform our competition response, we are launching a joint market engagement exercise to explore innovative ideas, technologies, and service models that could inform our competition entries and shape future service opportunities in obesity prevention and management in our ICBs.